Regulatory Affairs Syndicator

Street.Com - Novartis asked the Food and Drug Administration to vote in support of Prexige in 2002, but the agency wanted more clinical data. The Swiss drugmaker later withdrew the request to conduct more tests. Novartis now says it will refile its application …